Scan to Download
Indian equities ended lower, resuming declines after a one-day breather. The indices, however, managed to pare early losses, led by the gains in Tata Consultancy Services Ltd. and Infosys Ltd.
The S&P BSE Sensex fell 0.55 percent to end at 38,409.48 after declining as much as 2.01 percent earlier. The NSE Nifty 50 fell 0.45 percent to close at 11,252.20 after declining as much as 1.96 percent earlier. The broader markets represented by the NSE Nifty 500 Index ended 0.7 percent lower after falling as much as 2.13 percent earlier.
The market breadth was tilted in favour of sellers. About 1,291 stocks declined and 533 shares advanced on National Stock Exchange.
Nine out of 11 sectoral gauges compiled by the NSE ended lower, led by the NSE Nifty Private Bank Index’s 1.8 percent fall. On the flipside, the NSE Nifty Pharma Index was the top sectoral gainer, up 2.1 percent.
Chalet Hotels
Tube Investments
Oriental Bank of Commerce
FDC India
BASF India
Essel Propack
3M India
Dr. Reddy’s Laboratories
Indian equities traded off day’s low.
The S&P BSE Sensex fell 0.77 percent to 38,338 after declining as much as 2 percent earlier. The NSE Nifty 50 fell 0.52 percent to 11,247 after declining as much as 1.96 percent earlier.
Jubilant FoodWorks
Bajaj Finance
Domestic fund houses are said to be accumulating the stock at lower levels.
Tata Motors & Tata Elxsi
Stocks mentioned on Dealers' say are based on conversations with brokerage houses and not thoroughly researched. Please consult a registered financial stock adviser before buying/selling any of these stocks.
Shares of BASF India rose for the second consecutive trading session. The stock rose as much as 12.7 percent to Rs 1,144, the highest since July 19, 2019.
Trading volume was almost four times its 20-day average, Bloomberg data showed. The Relativ Strength Index was above 70, indicating that the stock may be oversold.
Indian equities traded lower but recovered marginally from day’s low.
The S&P BSE Sensex fell 1.36 percent to 38,088 after declining as much as 2 percent earlier. The NSE Nifty 50 fell 1.24 percent to 11,163 after declining as much as 1.96 percent earlier.
The market breadth was tilted in favour of sellers. About 1,445 stocks declined and 357 shares advanced on National Stock Exchange.
ITC Ltd. lost about Rs 2.5 lakh crore in market capitlisation in seven trading sessions.
The stock fell 7 percent in seven days. Today, the scrip fell as much as 3.8 percent to trade at more than a four-year low at Rs 186.55.
Shares of Lemon Tree Hotels decline for the seventh consecutive trading session. The stock fell as much as 7.6 percent to hit an all-time low at Rs 45.70.
The company lost Rs 1,355 crore in market capitalization in seven days. The scrip traded at 39.6 times its estimated earnings per share compared to 55.6 times for the two-year historical average, according to Bloomberg data. The Relative Strength Index was at 29, indicating that the stock may be oversold.
Share of IRCTC hit their lower circuit of 10 percent at Rs 1,565.40.
The stock had declined in six out of seven trading sessions. The scrip fell 18 percent in the past five days and rose 14 percent in the past 30 days, according to Bloomberg data.
U.S. stock futures rebounded after Tuesday’s sharp decline, and European contracts rose, as investors took in Super Tuesday election results alongside the Federal Reserve’s emergency interest-rate cut.
The total number of people tested positive for coronavirus in India has risen to 28, of which three people from Kerala have been cured, Health Minister Harsh Vardhan said today in a briefing.
Key Highlights:
Catch all the live updates on Coronavirus in India here.
Shares of Sun Pharma Advanced Research Company extended gains for the second consecutive trading session. The stock rose as much as 9.2 percent, the most in nearly three months, to Rs 161.70.
The scrip was the second-best performer on the NSE Nifty 500 Index. It returned 12 percent in two trading sessions.
Trading volume was six times its 20-day average, according to Bloomberg data.
Shares of Future Consumer extended gains for the third consecutive trading session. The stock rose s much as 9.7 percent, the most since March 3, to Rs 15.25, the highest since Feb. 27, 2020.
The scrip advanced 23.9 percent in three trading sessions. Prior to March 2, shares of the company had declined for 10 trading sessions.
The stock declined 68 percent in the past 12 months compared to a 6.6 percent gain in the Sensex.
Indian equities erased morning gains and declined to trade at day’s low.
The S&P BSE Sensex fell as much a 0.74 percent to 38,338.87 and the NSE Nifty 50 fell as much as 0.66 percent to 11,229. The broader markets represented by the NSE Nifty 500 Index fell as much as 0.74 percent.
Shares of Karur Vysya Bank fell for the ninth consecutive trading session, their longest stretch of losses in nearly 17 months.
The stock fell as much as 5.2 percent to Rs 37.05, the lowest since February 2010. The scrip declined 25 percent in nine trading sessions.
The company lost Rs 924 crore in market capitalisation. The relative strength index was at 21, indicating that the stock may be oversold, Bloomberg data showed.
Ten out of 18 analysts tracked by Bloomberg had a ‘Buy’ rating on the stock. The scrip, however, traded below its consensus price target since October 2017.
The Supreme Court today has set aside RBI circular which had barred banks from being involved in cryptocurrency trading.
The Markit India Services Business Activity Index rose to 57.5 last month from 55.5 in January, according to a statement. A reading below 50 indicates contraction in activity, while a number above it signals expansion.
The Markit India Composite PMI Output Index also rose to 57.6 in February from 56.3 in the previous month.
Shares of Yes Bank extended declines for the fourth consecutive trading session. The stock fell as much as 5.1 percent to Rs 29.60.
About 12.8 lakh shares of the lender changed hands in a large trade, Bloomberg data showed. Buyers and sellers were not known immediately.
Besides, Reliance Infrastructure has defaulted on payment of dues worth Rs 52 crore. The total loan amount worth Rs 3,729 crore is from a consortium of banks, from which Rs 3,627 crore is taken from Yes Bank.
Of the shares traded, 52 percent were at the ask price and 46 percent were at the bid, according to Bloomberg data. The scrip was the worst performer on the Nifty had has declined 20 percent in four days.
Nifty’s 11,400 call option contract was among the most active Nifty option contracts on National Stock Exchange.
Premium on the contract, which is set to expire on March 5, dropped 28.6 percent to Rs 38.20. About 6.25 lakh shares were added to the open interest which stood at over 22.29 lakh shares.
Shares of the drugmaker extended gains for the second consecutive trading session. The stock rose as much as 1.9 percent to Rs 575.70. It ended 6.3 percent higher on Tuesday
The Bengaluru-based pharma company gained as much as two percent after getting a U.S. FDA approval for its Tetracycline Hydrochloride Capsule. The approval has come from its flagship facility in Bengaluru. The said drug will be marketed in the U.S. Markets, where it is estimated to have sales of $16 million, according to the company's media statement.
Tetracycline Hydrochloride Capsule is used to treat different bacterial infections of the skin and other body systems.
Shares of Hindustan Aeronautics fell as much as 5.1 percent to Rs 638.
The state-run firm said that it has received notice from International Court of Arbitration on request for arbitration from RUAG Aerospace Services GMBH. The company said that it has initiated necessary action with respect to the arbitration process.
The amount in dispute partially quantified by the opposition party is $21,872,500 or Rs 160.25 crore against alleged damages on breach of agreement regarding the supply of structural parts for the production of Dornier-228, by the company.
Shares of Vedanta resumed declines after a one-day breather. The stock fell as much as 3.7 percent to Rs 115.10.
Moody's Investors Service has downgraded Vedanta’s corporate family rating to B1 from Ba3. Moody's has also downgraded the rating on senior unsecured bonds issued by Vedanta and those issued by its wholly-owned subsidiary, Vedanta Resources Finance II Plc and guaranteed by Vedanta, to B3 from B2. The outlook on all ratings is stable. The downgrade was triggered by a sustained deterioration in the company's credit profile.
The scrip traded at 7.4 times its estimated earnings per share for the coming year, according to Bloomberg data. The stock declined 11 percent the past five days and dropped 6 percent in the past 30 days.
Shares of HFCL rose as much as 6.7 percent, the most since Dec. 4, 2019, to Rs 13.50.
The company received a purchase order worth Rs 196 crore from L&T for the supply of optical fibre cables for construction of Telangana Fiber Grid.
Trading volume was more than five times its 20-day average, Bloomberg data showed. The Relative Strength Index was below 30, indicating that the stock may be oversold.
Indian equities opened higher, extending gains for the second consecutive trading session.
The S&P BSE Sensex and the NSE Nifty 50 traded little changed at 38,570 and 11,287.35 respectively after gaining over 0.4 percent earlier. The broader markets represented by the NSE Nifty 500 Index fell as much as 0.4 percent.
The market breadth was tilted in favour of buyers. About 958 stocks advanced and 438 shares declined on National Stock Exchange.
Six out of 11 sectoral gauges compiled by the NSE traded lower, led by the NSE Nifty Metal Index’s 0.8 percent fall. On the flipside, the NSE Nifty IT Index was the top sectoral gainer, up 0.86 percent.
Indian equities are set for a positive start.
The S&P BSE Sensex rose 0.28 percent to 38,733 during the pre-market trade and the NSE Nifty 50 rose 1.06 percent to 11,418.
Get your daily fix of global markets here.
Disclaimer: The commentary on BloombergQuint represents the view of external experts. Investors are advised to consult a certified financial advisor/planner when making any investments. No views shared on a BloombergQuint program or story or conversation should be construed as personal advice.
Quintillion Business Media Pvt. (BloombergQuint) is not responsible for any risk or loss that might occur as a result of using this information in any way, regardless of your interpretation of the advice.
BloombergQuint’s digital and social media platforms provide views of only SEBI registered investment advisors/analysts.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
